Omalizumab Therapy in Evolving Allergic Bronchopulmonary Aspergillosis

Omalizumab Therapy in Evolving Allergic Bronchopulmonary Aspergillosis

The therapy has been very well-tolerated over this interval, encouraging further utilization of anti-IgE monoclonal antibody therapy in other cases of ABPA.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2007, Vol.119 (1), p.S211-S211
Hauptverfasser: Dave, S, Cherry, W.B, Maddox, D.E
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The therapy has been very well-tolerated over this interval, encouraging further utilization of anti-IgE monoclonal antibody therapy in other cases of ABPA.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2006.12.198